250 related articles for article (PubMed ID: 24253043)
1. FGF16 promotes invasive behavior of SKOV-3 ovarian cancer cells through activation of mitogen-activated protein kinase (MAPK) signaling pathway.
Basu M; Mukhopadhyay S; Chatterjee U; Roy SS
J Biol Chem; 2014 Jan; 289(3):1415-28. PubMed ID: 24253043
[TBL] [Abstract][Full Text] [Related]
2. Wnt/β-catenin pathway is regulated by PITX2 homeodomain protein and thus contributes to the proliferation of human ovarian adenocarcinoma cell, SKOV-3.
Basu M; Roy SS
J Biol Chem; 2013 Feb; 288(6):4355-67. PubMed ID: 23250740
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of PITX2 transcription factor contributes to ovarian cancer progression.
Fung FK; Chan DW; Liu VW; Leung TH; Cheung AN; Ngan HY
PLoS One; 2012; 7(5):e37076. PubMed ID: 22615897
[TBL] [Abstract][Full Text] [Related]
4. Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.
Basu M; Bhattacharya R; Ray U; Mukhopadhyay S; Chatterjee U; Roy SS
Mol Cancer; 2015 Aug; 14():162. PubMed ID: 26298390
[TBL] [Abstract][Full Text] [Related]
5. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway.
Yoshioka S; King ML; Ran S; Okuda H; MacLean JA; McAsey ME; Sugino N; Brard L; Watabe K; Hayashi K
Mol Cancer Res; 2012 Mar; 10(3):469-82. PubMed ID: 22232518
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 2 induces E-cadherin down-regulation via PI3K/Akt/mTOR and MAPK/ERK signaling in ovarian cancer cells.
Lau MT; So WK; Leung PC
PLoS One; 2013; 8(3):e59083. PubMed ID: 23554977
[TBL] [Abstract][Full Text] [Related]
8. ETS-1 protein regulates vascular endothelial growth factor-induced matrix metalloproteinase-9 and matrix metalloproteinase-13 expression in human ovarian carcinoma cell line SKOV-3.
Ghosh S; Basu M; Roy SS
J Biol Chem; 2012 Apr; 287(18):15001-15. PubMed ID: 22270366
[TBL] [Abstract][Full Text] [Related]
9. MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.
Zhai Y; Iura A; Yeasmin S; Wiese AB; Wu R; Feng Y; Fearon ER; Cho KR
Oncogene; 2011 Oct; 30(40):4152-62. PubMed ID: 21499300
[TBL] [Abstract][Full Text] [Related]
10. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
[TBL] [Abstract][Full Text] [Related]
11. Wnt/beta-catenin signaling promotes expansion of Isl-1-positive cardiac progenitor cells through regulation of FGF signaling.
Cohen ED; Wang Z; Lepore JJ; Lu MM; Taketo MM; Epstein DJ; Morrisey EE
J Clin Invest; 2007 Jul; 117(7):1794-804. PubMed ID: 17607356
[TBL] [Abstract][Full Text] [Related]
12. MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.
Wu G; Liu A; Zhu J; Lei F; Wu S; Zhang X; Ye L; Cao L; He S
Oncotarget; 2015 Oct; 6(30):28882-94. PubMed ID: 26337084
[TBL] [Abstract][Full Text] [Related]
13. Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis.
Kwon M; Lee SJ; Wang Y; Rybak Y; Luna A; Reddy S; Adem A; Beaty BT; Condeelis JS; Libutti SK
Int J Cancer; 2014 Jul; 135(1):48-60. PubMed ID: 24327474
[TBL] [Abstract][Full Text] [Related]
14. Integrin regulation of beta-catenin signaling in ovarian carcinoma.
Burkhalter RJ; Symowicz J; Hudson LG; Gottardi CJ; Stack MS
J Biol Chem; 2011 Jul; 286(26):23467-75. PubMed ID: 21518759
[TBL] [Abstract][Full Text] [Related]
15. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts secrete FGF-1 to promote ovarian proliferation, migration, and invasion through the activation of FGF-1/FGFR4 signaling.
Sun Y; Fan X; Zhang Q; Shi X; Xu G; Zou C
Tumour Biol; 2017 Jul; 39(7):1010428317712592. PubMed ID: 28718374
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades.
Katoh M; Katoh M
Cancer Biol Ther; 2006 Sep; 5(9):1059-64. PubMed ID: 16940750
[TBL] [Abstract][Full Text] [Related]
19. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
20. FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway.
Zhang Y; Wang CP; Ding XX; Wang N; Ma F; Jiang JH; Wang QD; Chang JB
Asian Pac J Cancer Prev; 2014; 15(16):6829-35. PubMed ID: 25169533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
